China Cracks Down On Device Clinical Data Forgery, Problematic Manufacturing
This article was originally published in PharmAsia News
Executive Summary
Drawing success from a recent compliance campaign targeting drug makers in China, CFDA is now clamping down on the medical device industry, underscoring concerns over frequent violations and quality issues amid the sector’s fast growth.